<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Med Rep</journal-id><journal-id journal-id-type="iso-abbrev">Mol Med Rep</journal-id><journal-title-group><journal-title>Molecular Medicine Reports</journal-title></journal-title-group><issn pub-type="ppub">1791-2997</issn><issn pub-type="epub">1791-3004</issn><publisher><publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7716405</article-id><article-id pub-id-type="pmid">33236154</article-id><article-id pub-id-type="doi">10.3892/mmr.2020.11716</article-id><article-id pub-id-type="publisher-id">MMR-0-0-11716</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title><italic>Inonotus obliquus</italic> extract alleviates myocardial ischemia/reperfusion injury by suppressing endoplasmic reticulum stress</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Yi</given-names></name><xref ref-type="aff" rid="af1-mmr-0-0-11716">1</xref></contrib><contrib contrib-type="author"><name><surname>Cui</surname><given-names>Heming</given-names></name><xref ref-type="aff" rid="af1-mmr-0-0-11716">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yuying</given-names></name><xref ref-type="aff" rid="af1-mmr-0-0-11716">1</xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Ping</given-names></name><xref ref-type="aff" rid="af1-mmr-0-0-11716">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yuangeng</given-names></name><xref ref-type="aff" rid="af1-mmr-0-0-11716">1</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Dan</given-names></name><xref ref-type="aff" rid="af1-mmr-0-0-11716">1</xref></contrib><contrib contrib-type="author"><name><surname>Xue</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="af1-mmr-0-0-11716">1</xref><xref ref-type="aff" rid="af2-mmr-0-0-11716">2</xref><xref rid="c2-mmr-0-0-11716" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>Fu</surname><given-names>Wenwen</given-names></name><xref ref-type="aff" rid="af1-mmr-0-0-11716">1</xref><xref rid="c1-mmr-0-0-11716" ref-type="corresp"/></contrib></contrib-group><aff id="af1-mmr-0-0-11716"><label>1</label>Department of Pharmacology, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130021, P.R. China</aff><aff id="af2-mmr-0-0-11716"><label>2</label>Department of Burn Surgery, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China</aff><author-notes><corresp id="c1-mmr-0-0-11716"><italic>Correspondence to</italic>: Dr Wenwen Fu, Department of Pharmacology, School of Pharmaceutical Sciences, Jilin University, 1266 Fujin Road, Changchun, Jilin 130021, P.R. China, E-mail: <email>fww@jlu.edu.cn</email></corresp><corresp id="c2-mmr-0-0-11716">Dr Yan Xue, Department of Burn Surgery, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, Jilin 130021, P.R. China, E-mail: <email>xueyan0905@jlu.edu.cn</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2021</year></pub-date><pub-date pub-type="epub"><day>23</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>11</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>23</volume><issue>1</issue><elocation-id>77</elocation-id><history><date date-type="received"><day>17</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>10</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Wu et al.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions><abstract><p><italic>Inonotus obliquus</italic> (IO) is an edible fungus that exerts various biological functions, including anti-inflammatory, antitumor and immunomodulatory effects. The present study was designed to investigate the role of IO extract (IOE) in myocardial ischemia/reperfusion (MI/R) and determine the exact molecular mechanisms. The left anterior descending coronary artery was ligated to establish the MI/R injury model in rats. IOE exhibited a novel cardioprotective effect, as shown by improvement in cardiac function and decrease in infarct size. Pretreatment with IOE activated antioxidant enzymes in cardiomyocytes, including glutathione peroxidase, superoxide dismutase and catalase. IOE pretreatment also induced the upregulation of NAD-dependent protein deacetylase sirtuin-1 (SIRT1) and downregulation of glucose-regulated protein 78, phosphorylated (p-) protein kinase R-like endoplasmic reticulum kinase, p-eukaryotic translation initiation factor 2 subunit &#x003b1;, C/EBP homologous protein and caspase-12. Furthermore, IOE alleviated endoplasmic reticulum (ER) stress-induced apoptosis in cardiomyocytes by decreasing the mRNA levels of <italic>caspase-12</italic>. IOE inhibited apoptosis induced by overexpression of pro-caspase-9 and pro-caspase-3. In summary, IOE pretreatment protects the heart against MI/R injury through attenuating oxidative damage and suppressing ER stress-induced apoptosis, which may be primarily due to SIRT1 activation.</p></abstract><kwd-group><kwd><italic>Inonotus obliquus</italic> extract</kwd><kwd>myocardial ischemia/reperfusion injury</kwd><kwd>NAD-dependent protein deacetylase sirtuin-1</kwd><kwd>endoplasmic reticulum stress</kwd><kwd>apoptosis</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Cardiovascular disease is a challenging disease with high morbidity and mortality worldwide (<xref rid="b1-mmr-0-0-11716" ref-type="bibr">1</xref>). Myocardial ischemia/reperfusion (MI/R) injury is the primary risk factor in the pathological process of heart disease. Although reperfusion is the most efficient way to mimic tissue damage, the re-establishment of the blood supply is known to induce various adverse events (<xref rid="b2-mmr-0-0-11716" ref-type="bibr">2</xref>). In addition, MI/R also induces endoplasmic reticulum (ER) stress and activates apoptosis-related signaling pathways (<xref rid="b3-mmr-0-0-11716" ref-type="bibr">3</xref>).</p><p>The ER serves a number of roles in protein synthesis, lipid biosynthesis and detoxification. When normal ER function is disrupted by various cellular disturbances, unfolded and misfolded proteins accumulate, resulting in a condition known as ER stress (<xref rid="b4-mmr-0-0-11716" ref-type="bibr">4</xref>). The alteration of redox homeostasis results in excessive generation of reactive oxygen species (ROS), which subsequently causes ER stress (<xref rid="b5-mmr-0-0-11716" ref-type="bibr">5</xref>). ER stress promotes the dissociation of the ER chaperone glucose-regulated protein 78 (GRP78) from transmembrane proteins and triggers their activation (<xref rid="b6-mmr-0-0-11716" ref-type="bibr">6</xref>). Protein kinase R-like endoplasmic reticulum kinase (PERK) is one of transmembrane proteins and dimerizes under ER stress, which phosphorylates eukaryotic translation initiation factor 2 subunit &#x003b1; (eIF2&#x003b1;) (<xref rid="b7-mmr-0-0-11716" ref-type="bibr">7</xref>). eIF2&#x003b1; mediates the transcription of activating transcription factor-4 (ATF4), which interacts with the pro-apoptotic factor C/EBP homologous protein (CHOP) (<xref rid="b8-mmr-0-0-11716" ref-type="bibr">8</xref>). Additionally, ER stress induces cell apoptosis by activating the caspase family cascade (<xref rid="b9-mmr-0-0-11716" ref-type="bibr">9</xref>).</p><p>NAD-dependent protein deacetylase sirtuin-1 (SIRT1), known as one of the mammalian homologues of yeast Sir2, is a histone deacetylase and regulates various biological processes, such as the inflammatory reaction, oxidative stress and apoptosis (<xref rid="b10-mmr-0-0-11716" ref-type="bibr">10</xref>,<xref rid="b11-mmr-0-0-11716" ref-type="bibr">11</xref>). A previous study demonstrated that SIRT1 overexpression protects cardiomyocytes against MI/R injury from ER stress (<xref rid="b12-mmr-0-0-11716" ref-type="bibr">12</xref>). The protective effect is due to the activation of the PERK/eIF2&#x003b1; pathway, which is associated with cardiomyocyte apoptosis. Hence, SIRT1 may be a potential target to treat cardiac pathologies by attenuating ER stress.</p><p><italic>Inonotus obliquus</italic> (IO) is a fungus belonging to the Hymenochaetaceae family of Basidiomycetes, which grows on birch trees (<xref rid="b13-mmr-0-0-11716" ref-type="bibr">13</xref>). The main bioactive compounds of IO are polysaccharides, polyphenols, melanin and triterpenes (<xref rid="b14-mmr-0-0-11716" ref-type="bibr">14</xref>). IO exerts various biological functions, including anti-inflammatory, antitumor and immunomodulatory effects (<xref rid="b15-mmr-0-0-11716" ref-type="bibr">15</xref>,<xref rid="b16-mmr-0-0-11716" ref-type="bibr">16</xref>). However, its effects on cardiovascular diseases has been rarely studied. The current study was designed to investigate the role of IO extract (IOE) in MI/R injury and determine the exact molecular mechanisms.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title/><sec><title>Ethanol extraction of IO</title><p>IO was collected from Jilin Province, Northeastern China and identified by Professor GuangShu Wang (Jilin University). A total of 2,500 g IO powder was weighed, soaked in 12.5 l distilled water overnight at room temperature and extracted at 80&#x000b0;C for 2.5 h. The supernatant was collected after filtration using three layers of gauze, and the extraction was repeated twice in the same manner. The filtrate was concentrated by rotary evaporation, dried at 60&#x000b0;C, crushed and passed through an 80-mesh sieve to obtain the preliminary extract. Next, 12.5 l 70% ethanol was added to the preliminary extract obtained from water extraction (extracted at 75&#x000b0;C for 2.5 h). The supernatant was gathered by filtering through three layers of gauze, and the extraction was repeated twice in the same manner. The filtrates were collected and concentrated by rotary evaporation, then dried at 60&#x000b0;C, crushed and passed through an 80-mesh sieve, and 127.9 g IOE was obtained. The extraction rate of IOE was 5.12% according to the following formula: Extraction rate = weight of IOE/weight of IO powder. Meanwhile, the main composition of IOE was assessed using a T-6 Series UV&#x02013;Vis spectrophotometer (Beijing Purkinje General Instrument Co., Ltd.). The contents of total flavonoid, total saponin, polysaccharide and polyphenol were calculated using respective standard curves (y=0.0117&#x000d7;+0.0554, R<sup>2</sup>=0.9998; y=0.0301&#x000d7;+0.0871, R<sup>2</sup>=0.9992; y=16.253&#x000d7;+0.1019, R<sup>2</sup>=0.9999 and y=97.266&#x000d7;+0.1984, R<sup>2</sup>=0.9996) with the percentage of 1.76, 1.06, 0.57 and 1.07%.</p></sec><sec><title>Animals</title><p>Wistar rats (female, 250&#x02013;280 g) were purchased from Changchun Yisi Experimental Animal Co., Ltd., and raised in a controlled environment (22&#x02013;24&#x000b0;C; 55&#x02013;60% humidity and 12/12-h light/dark cycle) with free access to food and water. Animals were treated according to the Guide for the Care and Use of Laboratory Animals (US National Institutes of Health) (<xref rid="b17-mmr-0-0-11716" ref-type="bibr">17</xref>) and the Committee for the Care and Use of Laboratory Animals of Jilin University (Changchun, China). The animal experiments of the present study were approved by the Ethical Committee for Experimental Animals, School of Pharmaceutical Sciences, Jilin University (approval no. 20190049).</p></sec><sec><title>Experimental design</title><p>A total of 150 female rats were randomly assigned into five groups (n=30): i) Non-MI/R sham group (Sham); ii) MI/R group (MI/R); iii) MI/R+IOE 150 mg/kg group (MI/R-IOE150); iv) MI/R+IOE 300 mg/kg group (MI/R-IOE300) and v) MI/R+IOE 600 mg/kg group (MI/R-IOE600). The animals in the treatment groups were intragastrically administered with IOE (150, 300 or 600 mg/kg) for 7 consecutive days. The rats of the Sham and MI/R groups were intragastrically administered with 0.5% carboxymethylcellulose sodium for 7 consecutive days. Surgical procedures were performed on rats in the Sham group, but without left anterior descending (LAD) coronary artery ligation. In other groups, LAD ligation was performed on the hearts for 2 h and then reperfused for 2 h.</p></sec><sec><title>Experimental model establishment</title><p>At day 7, 3% sodium pentobarbital (30 mg/kg body weight, intraperitoneal injection) was used to anesthetize the rats after 1 h of administration. Rat hearts were exteriorized via open-chest surgery. A 6/0 nylon suture was put to make a slip knot around the LAD coronary artery and induce myocardial ischemia. After 2 h of ligation, the ligature was loosened to restore myocardial blood supply for myocardial reperfusion. Rats in the Sham group were subjected to the same procedure, but without ligation. Reperfusion was performed for 2 h. The rats were anesthetized by intraperitoneal injection with 3% sodium pentobarbital (30 mg/kg body weight). Then, ~8 ml volume of blood was taken from the abdominal aorta of the unconscious rats for painless euthanasia. Death was confirmed when respiratory and cardiac arrest was observed, following which, cardiac tissues were harvested for further experiments.</p></sec><sec><title>Cardiac function assessment</title><p>After 2 h of reperfusion, 3% sodium pentobarbital (30 mg/kg body weight, intraperitoneal injection) was used to anesthetize the rats. Once anesthetized, the thoracic area was shaved and covered with ultrasonic transmission gel. A portable echocardiography machine (GE Vivid I; GE Healthcare) was used to evaluate the cardiac function of rats. The left ventricular (LV) ejection fraction (EF), LV fractional shortening (FS), LV internal dimensions at diastole (LVIDd) and LV internal diameter systole (LVIDs) were evaluated. An observer who was blinded to the experimental design measured these parameters in three consecutive cardiac cycles.</p></sec><sec><title>Determination of myocardial infarction size (MIS)</title><p>After 2 h of reperfusion, the heart tissues were excised to perform MIS measurements. Five pieces of the left ventricle parallel to the atrioventricular groove were transected, immersed in 0.5% nitro blue tetrazolium chloride (NBT) phosphate buffer and stained for 1 min in a 37&#x000b0;C water bath. Normal myocardial tissues were stained dark red, while ischemic myocardial tissues were pale. The ischemic myocardial tissue was excised and weighed. The MIS was calculated as follows: Ischemic myocardial weight/wet weight of the left ventricle &#x000d7;100%.</p></sec><sec><title>Determination of cardiac enzymes</title><p>A total of 2 ml blood was collected after 2 h of reperfusion. Serum was separated from the blood samples by centrifugation (2,000 &#x000d7; g, 10 min, 4&#x000b0;C) and used for the evaluation of creatine kinase-MB (CK-MB; cat. no. H197; Nanjing Jiancheng Bioengineering Institute), aminotransferase (AST; cat. no. C010-1-1; Nanjing Jiancheng Bioengineering Institute) and lactate dehydrogenase (LDH; cat. no. A020-2-2; Nanjing Jiancheng Bioengineering Institute) activities using respective diagnostic kits in accordance with the manufacturer's instructions.</p></sec><sec><title>Determination of oxidative stress levels in myocardial tissue</title><p>After 2 h of reperfusion, rat hearts were excised to prepare heart homogenates. Prepared myocardial tissues were excised and homogenized (10%) in ice-cold physiological saline solution using a Tissue-Tearor (Bio Spec Products, Inc.). The supernatant was separated from heart homogenates by centrifugation (3,500 &#x000d7; g, 15 min, 4&#x000b0;C) and used for the evaluation of superoxide dismutase (SOD; cat. no. A001-1-2; Nanjing Jiancheng Bioengineering Institute), malondialdehyde (MDA; cat. no. A003-1-1; Nanjing Jiancheng Bioengineering Institute), glutathione peroxidase (GSH-px; cat. no. A005-1-2; Nanjing Jiancheng Bioengineering Institute) and catalase (CAT; cat. no. A007-2-1; Nanjing Jiancheng Bioengineering Institute) levels using respective diagnostic kits in accordance with the manufacturer's instructions.</p></sec><sec><title>Histological examination</title><p>After 2 h of reperfusion, rat hearts were quickly harvested. and the blood was expelled. Hearts were fixed in 4% paraformaldehyde solution for 24 h at room temperature. After rinsing with water, heart tissues were dehydrated with gradient ethanol solution and embedded in paraffin. Subsequently, heart tissues were cut into 3&#x02013;5 &#x000b5;m-thick slices and stained using a hematoxylin and eosin (H&#x00026;E) kit for 3 min at room temperature. An optical microscope was used to observe morphological changes. The degree of cardiac damage was assessed by an independent researcher blind to the experimental design.</p></sec><sec><title>TUNEL assay</title><p>Myocardial apoptosis was evaluated using a TUNEL assay kit (cat. no. 11684817910; Sigma-Aldrich; Merck KGaA). Heart tissue was fixed in 4% paraformaldehyde solution for 24 h at room temperature, embedded in paraffin, then sectioned on slides at 3&#x02013;5 &#x000b5;m-thickness. TUNEL (1:9 mixed in equilibration buffer) staining of apoptotic cells (green fluorescence). DAPI (5 &#x000b5;g/ml) was used to dye the nuclei for 5 min (blue fluorescence). The slides were then sealed with 50% glycerin. Five randomly selected fields of view were observed and apoptotic cells of each section were counted under an ECLIPSE 80i fluorescence microscope (Nikon Corporation). The cardiomyocyte apoptotic index (AI) was counted as follows: Number of TUNEL-positive nuclei/the number of total nuclei &#x000d7;100%.</p></sec><sec><title>Reverse transcription-quantitative (RT-q)PCR</title><p>Total RNA was extracted from cardiac tissues using TRIzol<sup>&#x000ae;</sup> reagent (Invitrogen; Thermo Fisher Scientific, Inc.), quantified with the T-6 Series UV&#x02013;VIS spectrophotometer (Beijing Purkinje General Instrument Co., Ltd.) and reverse transcribed into cDNA using a Hifair<sup>&#x000ae;</sup> II First Strand cDNA Synthesis Kit (cat. no. 11120ES60; Shanghai Yeasen Biotechnology Co., Ltd.). RT was carried out at 42&#x000b0;C for 15 min, then 85&#x000b0;C for 15 sec. Subsequently, qPCR was performed with sequence-specific primers using the SYBR Green Master Mix kit (cat. no. 11202ES03; Shanghai Yeasen Biotechnology Co., Ltd.). The thermocycling conditions consisted of 40&#x02013;50 cycles at 95&#x000b0;C for 10 sec, 55&#x000b0;C for 20 sec and 72&#x000b0;C, 20 sec. The following primer pairs were used for qPCR: <italic>Caspase-12</italic> forward, 5&#x02032;-CAGCACATTCCTGGTGTTTAT-3&#x02032; and reverse, 5&#x02032;-GACTCTGGCAGTTACGGTTGTT-3&#x02032; and <italic>&#x003b2;-actin</italic> forward, 5&#x02032;-GCACCGCAAATGCTTCTAGG-3&#x02032; and reverse, 5&#x02032;-AAAGGGTGTAAAACGCAGCTC-3&#x02032;. Data were calculated using the 2<sup>&#x02212;&#x02206;&#x02206;Cq</sup> method (<xref rid="b18-mmr-0-0-11716" ref-type="bibr">18</xref>) with the mRNA levels of <italic>&#x003b2;-actin</italic> as an internal control.</p></sec><sec><title>Western blot assay</title><p>Myocardial tissues were homogenized in lysis buffer (cat. no. P0013; Beyotime Institute of Biotechnology) and protease inhibitor cocktail on ice and purified by centrifugation at 14,000 &#x000d7; g for 15 min at 4&#x000b0;C. The protein concentration was determined using the BCA method. A total of 40 &#x000b5;g protein was loaded onto 10&#x02013;12% gels and resolved via SDS-PAGE. Separated proteins were then transferred to a PVDF membrane for 2 h. PVDF membranes were blocked for 1.5 h in 5% bovine serum albumin (cat. no. P0252; Beyotime Institute of Biotechnology) at room temperature and washed three times with TBS+0.2% Tween-20. Membranes were incubated overnight at 4&#x000b0;C with the following primary antibodies (all from Affinity Biosciences): SIRT1 (1:2,000; cat. no. DF6033), GRP78 (1:800; cat. no. AF5366), eIF2&#x003b1; (1:1,000; cat. no. AF6087; Affinity Biosciences), phosphorylated (p)-eIF2&#x003b1; (Ser52) (1:1,500; cat. no. AF3087), PERK (1:1,000; cat. no. AF5304), p-PERK (Thr982) (1:1,500; cat. no. DF7576), CHOP (1:1,500; cat. no. DF6025), caspase-12 (1:1,500; cat. no. AF5199), pro-caspase-3 (1:1,500; cat. no. AF6311), pro-caspase-9 (1:1,500; cat. no. AF6348) or anti-&#x003b2;-actin (1:5,000; cat. no. AF7018). A goat anti-rabbit secondary antibody (1:5,000; cat. no. IH-0011; Beijing Dingguo Changsheng Biotechnology Co., Ltd.) was used to observe primary antibody binding, and then bands were visualized using an ECL western blotting substrate (cat. no. KF001; Affinity Biosciences). Densitometric analysis of the bands was conducted using ImageJ software (version 1.5.1k; National Institutes of Health).</p></sec><sec><title>Statistical analysis</title><p>All data are presented as the mean &#x000b1; SD and were analyzed using SPSS 22.0 (IBM Corp.). Data were analyzed using one-way ANOVA followed by Tukey's Honest Significant Difference test. P&#x0003c;0.05 was considered to indicate a statistically significant difference.</p></sec></sec></sec><sec sec-type="results"><title>Results</title><sec><title/><sec><title>IOE improves cardiac function</title><p>The cardiac function of post-surgical hearts was evaluated by echocardiography. As shown in <xref rid="f1-mmr-0-0-11716" ref-type="fig">Fig. 1A-E</xref>, deterioration of cardiac function was induced in the MI/R group, LVIDd and LVIDs increased to 6.13&#x000b1;0.99 and 4.25&#x000b1;0.46 mm, respectively, whereas LVEF and LVFS decreased to 51.75&#x000b1;6.39 and 24.13&#x000b1;5.00%, respectively, compared with the Sham group (P&#x0003c;0.01). IOE pretreatment increased the recovery of cardiac function in the impaired hearts, which was demonstrated by increased LVEF and LVFS, as well as decreased LVIDd and LVIDs, compared with the M/R group (P&#x0003c;0.05 or P&#x0003c;0.01).</p></sec><sec><title>IOE decreases infarct size and attenuates MI/R Injury</title><p>NBT staining was used to observe the effects of IOE on the infarction scale. As shown in <xref rid="f2-mmr-0-0-11716" ref-type="fig">Fig. 2A</xref>, the infarct size reached up to 36.42&#x000b1;6.67% in the MI/R group. IOE (150, 300 and 600 mg/kg) significantly decreased the infarct size compared with the MI/R group (P&#x0003c;0.01). Furthermore, the activities of myocardial enzymes (LDH, CK-MB and AST) were significantly increased following MI/R injury compared with the Sham group, which further caused myocardial injury (P&#x0003c;0.01; <xref rid="f2-mmr-0-0-11716" ref-type="fig">Fig. 2B-D</xref>). IOE attenuated MI/R injury through inhibiting the activities of myocardial enzymes in MI/R-IOE groups (P&#x0003c;0.01).</p></sec><sec><title>IOE relieves myocardial tissue injury</title><p>Myocardial tissues showed partially disordered and disorderly arrangement of myocardial fiber stripes, and partial lysis of cardiomyocytes accompanied by interstitial edema in the MI/R group (<xref rid="f3-mmr-0-0-11716" ref-type="fig">Fig. 3</xref>). Following treatment with IOE, myocardial fibers and cell morphology notably improved to varying degrees.</p></sec><sec><title>IOE reduces oxidative stress</title><p>MDA content and antioxidant enzymes (SOD, GSH-px and CAT) are key molecules for evaluating the degree of oxidative stress. After MI/R, the activities of these antioxidant enzymes were significantly reduced (<xref rid="f4-mmr-0-0-11716" ref-type="fig">Fig. 4A, C and D</xref>). Meanwhile, the content of MDA was significantly higher compared with the Sham group (P&#x0003c;0.01; <xref rid="f4-mmr-0-0-11716" ref-type="fig">Fig. 4B</xref>). IOE pretreatment (150, 300 and 600 mg/kg) increased the activities of antioxidant enzymes and decreased MDA content compared with the MI/R group (P&#x0003c;0.01). These values indicated that IOE pretreatment protected cardiomyocytes against oxidative stress.</p></sec><sec><title>IOE decreases cardiomyocyte apoptosis</title><p>The present study aimed to detect the role of IOE in cell death by TUNEL staining. MI/R injury induced a certain degree of cardiomyocyte apoptosis by increasing the percentage of apoptotic cells in the MI/R group compared with the Sham group (P&#x0003c;0.01; <xref rid="f5-mmr-0-0-11716" ref-type="fig">Fig. 5A and B</xref>). As expected, pretreatment with IOE (150, 300 and 600 mg/kg) significantly decreased the percentage of apoptotic cells (P&#x0003c;0.05 or P&#x0003c;0.01). Therefore, the data suggested that IOE could alleviate cardiomyocyte apoptosis after MI/R injury.</p></sec><sec><title>IOE activates SIRT1 and downregulates the PERK/eIF2&#x003b1;/CHOP pathway</title><p>Considering the role of SIRT1 in cardioprotection, SIRT1 expression in heart tissue was examined. MI/R injury could suppress SIRT1 expression compared with the Sham group, which was then activated by IOE (P&#x0003c;0.01; <xref rid="f6-mmr-0-0-11716" ref-type="fig">Fig. 6A and B</xref>). Furthermore, upregulation of ER chaperone GRP78, p-PERK, p-eIF2&#x003b1;, CHOP and caspase-12 was observed after MI/R injury in the heart (P&#x0003c;0.01; <xref rid="f6-mmr-0-0-11716" ref-type="fig">Fig. 6A and C-G</xref>). Moreover, the changes in mRNA expression of <italic>caspase-12</italic> were investigated. As shown in <xref rid="f6-mmr-0-0-11716" ref-type="fig">Fig. 6H</xref>, the mRNA levels of <italic>caspase-12</italic> in the ischemic myocardium were also notably increased in the MI/R group compared with the Sham group (P&#x0003c;0.01). As expected, IOE inhibited ER stress by downregulating the expression of ER stress-related markers (GRP78, p-PERK, p-eIF2&#x003b1;, CHOP and caspase-12) compared with the MI/R group (P&#x0003c;0.05 or P&#x0003c;0.01). IOE decreased the mRNA levels of <italic>caspase-12</italic> in the MI/R-IOE groups (P&#x0003c;0.01). Collectively, the aforementioned values suggested that IOE attenuated MI/R injury by suppressing ER stress, which may be associated with SIRT1 activation.</p></sec><sec><title>IOE suppresses ER stress-induced apoptosis</title><p>To evaluate the condition of cardiomyocyte apoptosis, the expression of pro-caspase-9 and pro-caspase-3 in ischemic hearts were measured. MI/R injury significantly decreased the expression of pro-caspase-9 and pro-caspase-3 compared with the Sham group (P&#x0003c;0.01; <xref rid="f7-mmr-0-0-11716" ref-type="fig">Fig. 7A-C</xref>). By contrast, IOE increased the expression of pro-caspase-9 and pro-caspase-3 in ischemic heart tissue compared with the MI/R group (P&#x0003c;0.05 or P&#x0003c;0.01). The data indicated that IOE protected the heart from MI/R injury via suppressing ER stress-induced cardiomyocyte apoptosis.</p></sec></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>IO possesses various pharmacological and biological properties, including antitumor, antimicrobial and antioxidant activities (<xref rid="b19-mmr-0-0-11716" ref-type="bibr">19</xref>). It was previously reported that IO inhibited lipid peroxidation in hyperlipidemic rats (<xref rid="b20-mmr-0-0-11716" ref-type="bibr">20</xref>). In the present study, IOE exerted cardioprotective effects by attenuating oxidative damage and suppressing ER stress-induced apoptosis.</p><p>Redox signaling is crucial in the regulation of cell function, including defense against invading microorganisms and gene expression for physiological activity. MI/R induces excessive generation of redox signaling of ROS to break redox homeostasis, which results in oxidative stress (<xref rid="b21-mmr-0-0-11716" ref-type="bibr">21</xref>). The severity of reversible and irreversible cellular injury within cardiomyocytes is proportional to the level of ROS activation (<xref rid="b22-mmr-0-0-11716" ref-type="bibr">22</xref>). ROS can induce lipid peroxidation, protein oxidation and nitration, mitochondrial permeability transition and DNA damage, causing cardiomyocyte death following MI/R (<xref rid="b23-mmr-0-0-11716" ref-type="bibr">23</xref>). To keep the redox state in balance, redundant ROS is typically eliminated by several enzymes, such as SOD, GSH-px and CAT (<xref rid="b24-mmr-0-0-11716" ref-type="bibr">24</xref>). Several therapeutic strategies can protect cardiomyocytes by inhibiting oxidative stress, for example, pre-conditioning, pro-conditioning and antioxidants (<xref rid="b23-mmr-0-0-11716" ref-type="bibr">23</xref>). Our previous study revealed that ginsenoside Rg2 protected cardiomyocytes from MI/R injury by inhibiting oxidative stress and inflammation (<xref rid="b25-mmr-0-0-11716" ref-type="bibr">25</xref>). In the present study, MI/R injury induced downregulation of GSH-px, SOD and CAT activities and upregulation of MDA content, which were counteracted by IOE. These results indicated that IOE pretreatment protected cardiomyocytes against oxidative stress.</p><p>Ischemia and reperfusion activate a variety of cell death programs, categorized as apoptosis, necrosis or autophagy-associated cell death (<xref rid="b26-mmr-0-0-11716" ref-type="bibr">26</xref>). ER stress plays a vital role in the pathogenesis of cardiac diseases and may be a therapeutic target to protect cardiomyocytes. In the MI/R process, ER stress occurs due to diverse stimuli, and then triggers the unfolded protein response (UPR). Overproduction of ROS disrupts protein folding and results in amplified UPR signaling (<xref rid="b27-mmr-0-0-11716" ref-type="bibr">27</xref>). Previous evidence has suggested that UPR is initially activated by three endoplasmic reticulum stress sensors, serine/threonine-protein kinase/endoribonuclease IRE1, PERK and ATF6 (<xref rid="b28-mmr-0-0-11716" ref-type="bibr">28</xref>). GRP78, an immunoglobulin binding protein, physically binds to these proteins and inhibits their activities under a steady state (<xref rid="b29-mmr-0-0-11716" ref-type="bibr">29</xref>). PERK, also known as eukaryotic initiation factor 2&#x003b1; protein kinase 3, interacts with and phosphorylates eIF2&#x003b1; (<xref rid="b30-mmr-0-0-11716" ref-type="bibr">30</xref>). Under ER stress, PERK dissociates from GRP78 and induces the phosphorylation of eIF2&#x003b1;. The PERK/eIF2&#x003b1; signaling pathway can limit protein translation and induce apoptosis by inducing CHOP expression (<xref rid="b31-mmr-0-0-11716" ref-type="bibr">31</xref>). Caspase-12 localizes in the ER and is a critical mediator in ER stress-induced apoptosis by activating other caspases (<xref rid="b32-mmr-0-0-11716" ref-type="bibr">32</xref>). Caspase-12 specifically clears pro-caspase-9 for activation and caspase-9 is active. Subsequently, caspase-9 ultimately activates caspase-3, the major effector caspase for apoptosis (<xref rid="b33-mmr-0-0-11716" ref-type="bibr">33</xref>). In the present study, MI/R injury induced ER stress in rat cardiomyocytes. It was found that IOE pretreatment significantly decreased the expression of GRP78, p-PERK, p-eIF2&#x003b1;, CHOP and caspase-12 and the mRNA levels of <italic>Caspase-12</italic>. The present study also found that ER stress-induced apoptosis by MI/R injury was alleviated by IOE. Above all, the cardioprotective effects of IOE are based on the suppression of ER stress-induced cardiomyocyte apoptosis.</p><p>SIRT1 is a highly conserved histone deacetylase, which can deacetylate various transcription factors (<xref rid="b34-mmr-0-0-11716" ref-type="bibr">34</xref>). It has been demonstrated that SIRT1 activation has protective effects in myocardial ischemia. SIRT1 and ER stress are involved in various pathologies, including diabetes, obesity, cancer and cardiovascular diseases (<xref rid="b4-mmr-0-0-11716" ref-type="bibr">4</xref>,<xref rid="b35-mmr-0-0-11716" ref-type="bibr">35</xref>,<xref rid="b36-mmr-0-0-11716" ref-type="bibr">36</xref>). Resveratrol, a SIRT1 activator, inhibits ER stress via SIRT1 activation <italic>in vitro</italic> (<xref rid="b37-mmr-0-0-11716" ref-type="bibr">37</xref>). Previous studies have indicated that SIRT1 may regulate eIF2&#x003b1; phosphorylation via regulating its acetylation process, thereby affecting its activity (<xref rid="b38-mmr-0-0-11716" ref-type="bibr">38</xref>,<xref rid="b39-mmr-0-0-11716" ref-type="bibr">39</xref>). SIRT1 inhibition has been demonstrated to cause the hyperactivation of the PERK/eIF2&#x003b1; pathway, which induces cardiomyocyte apoptosis by sustaining CHOP expression (<xref rid="b12-mmr-0-0-11716" ref-type="bibr">12</xref>). The present study revealed that IOE notably increased SIRT1 expression in the ischemic myocardium. IOE also suppressed ER stress-induced apoptosis by mediating the PERK/eIF2&#x003b1;/CHOP signaling pathway. The present results demonstrated that IOE-induced SIRT1 activation may suppress ER stress-induced cardiomyocyte apoptosis, thereby reducing the infarct size <italic>in vivo</italic>. However, there is a complex interaction between SIRT1 and ER stress. SIRT1 activation has been reported to inhibit ER stress and apoptosis of cardiomyocytes by promoting autophagic clearance and decreasing the expression of the protein disulfide isomerase and S-nitrosylation (<xref rid="b40-mmr-0-0-11716" ref-type="bibr">40</xref>,<xref rid="b41-mmr-0-0-11716" ref-type="bibr">41</xref>). The role of IOE in these mechanisms need to be further studied.</p><p>In conclusion, the present findings showed that IOE pretreatment protected cardiomyocytes from MI/R injury by attenuating oxidative damage and suppressing ER stress-induced apoptosis. IOE may suppress ER stress-induced cardiomyocyte apoptosis via the PERK/eIF2&#x003b1;/CHOP pathway by the activation of SIRT1. Therefore, IO may be a potential therapeutic candidate in cardiovascular diseases.</p></sec></body><back><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><sec><title>Funding</title><p>This project was supported by the Jilin Scientific and Technological Development Program (grant no. 20190701056GH).</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></sec><sec><title>Authors' contributions</title><p>YX and WF conceived the study. YW, HC, YZ, PY, YL, DW, YX and WF performed the experiments. HC, YZ, PY, YL and DW analyzed the data. YW, YX and WF wrote the manuscript. YX and WF improved the manuscript. All authors read and approved the final manuscript.</p></sec><sec><title>Ethics approval and consent to participate</title><p>The animal experiments of this study were approved by the Ethical Committee for Experimental Animals, School of Pharmaceutical Sciences Jilin University (approval no. 20190049; Changchun, China).</p></sec><sec><title>Patient consent for publication</title><p>Not applicable.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><ref-list><title>References</title><ref id="b1-mmr-0-0-11716"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>D</given-names></name><name><surname>Thum</surname><given-names>T</given-names></name></person-group><article-title>RNA-based diagnostic and therapeutic strategies for cardiovascular disease</article-title><source>Nat Rev Cardiol</source><volume>16</volume><fpage>661</fpage><lpage>674</lpage><year>2019</year><pub-id pub-id-type="doi">10.1038/s41569-019-0218-x</pub-id><?supplied-pmid 31186539?><pub-id pub-id-type="pmid">31186539</pub-id></element-citation></ref><ref id="b2-mmr-0-0-11716"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robin</surname><given-names>E</given-names></name><name><surname>Guzy</surname><given-names>RD</given-names></name><name><surname>Loor</surname><given-names>G</given-names></name><name><surname>Iwase</surname><given-names>H</given-names></name><name><surname>Waypa</surname><given-names>GB</given-names></name><name><surname>Marks</surname><given-names>JD</given-names></name><name><surname>Hoek</surname><given-names>TL</given-names></name><name><surname>Schumacker</surname><given-names>PT</given-names></name></person-group><article-title>Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion</article-title><source>J Biol Chem</source><volume>282</volume><fpage>19133</fpage><lpage>19143</lpage><year>2007</year><pub-id pub-id-type="doi">10.1074/jbc.M701917200</pub-id><?supplied-pmid 17488710?><pub-id pub-id-type="pmid">17488710</pub-id></element-citation></ref><ref id="b3-mmr-0-0-11716"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name></person-group><article-title>ER stress-induced apoptosis: A novel therapeutic target in myocardial ischemia and reperfusion injury</article-title><source>Int J Cardiol</source><volume>214</volume><fpage>233</fpage><lpage>234</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.ijcard.2016.03.176</pub-id><?supplied-pmid 27077539?><pub-id pub-id-type="pmid">27077539</pub-id></element-citation></ref><ref id="b4-mmr-0-0-11716"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oakes</surname><given-names>SA</given-names></name><name><surname>Papa</surname><given-names>FR</given-names></name></person-group><article-title>The role of endoplasmic reticulum stress in human pathology</article-title><source>Annu Rev Pathol</source><volume>10</volume><fpage>173</fpage><lpage>194</lpage><year>2015</year><pub-id pub-id-type="doi">10.1146/annurev-pathol-012513-104649</pub-id><?supplied-pmid 25387057?><pub-id pub-id-type="pmid">25387057</pub-id></element-citation></ref><ref id="b5-mmr-0-0-11716"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>SS</given-names></name><name><surname>Kaufman</surname><given-names>RJ</given-names></name></person-group><article-title>Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease</article-title><source>Antioxid Redox Signal</source><volume>21</volume><fpage>396</fpage><lpage>413</lpage><year>2014</year><pub-id pub-id-type="doi">10.1089/ars.2014.5851</pub-id><?supplied-pmid 24702237?><pub-id pub-id-type="pmid">24702237</pub-id></element-citation></ref><ref id="b6-mmr-0-0-11716"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>AS</given-names></name></person-group><article-title>GRP78 induction in cancer: Therapeutic and prognostic implications</article-title><source>Cancer Res</source><volume>67</volume><fpage>3496</fpage><lpage>3499</lpage><year>2007</year><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-0325</pub-id><?supplied-pmid 17440054?><pub-id pub-id-type="pmid">17440054</pub-id></element-citation></ref><ref id="b7-mmr-0-0-11716"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>HP</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><article-title>Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase</article-title><source>Nature</source><volume>397</volume><fpage>271</fpage><lpage>274</lpage><year>1999</year><pub-id pub-id-type="doi">10.1038/16729</pub-id><?supplied-pmid 9930704?><pub-id pub-id-type="pmid">9930704</pub-id></element-citation></ref><ref id="b8-mmr-0-0-11716"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>HP</given-names></name><name><surname>Novoa</surname><given-names>I</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Wek</surname><given-names>R</given-names></name><name><surname>Schapira</surname><given-names>M</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><article-title>Regulated translation initiation controls stress-induced gene expression in mammalian cells</article-title><source>Mol Cell</source><volume>6</volume><fpage>1099</fpage><lpage>1108</lpage><year>2000</year><pub-id pub-id-type="doi">10.1016/S1097-2765(00)00108-8</pub-id><?supplied-pmid 11106749?><pub-id pub-id-type="pmid">11106749</pub-id></element-citation></ref><ref id="b9-mmr-0-0-11716"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Endoplasmic reticulum stress is the crossroads of autophagy, inflammation, and apoptosis signaling pathways and participates in liver fibrosis</article-title><source>Inflamm Res</source><volume>64</volume><fpage>1</fpage><lpage>7</lpage><year>2015</year><pub-id pub-id-type="doi">10.1007/s00011-014-0772-y</pub-id><?supplied-pmid 25286903?><pub-id pub-id-type="pmid">25286903</pub-id></element-citation></ref><ref id="b10-mmr-0-0-11716"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Ubaid</surname><given-names>S</given-names></name></person-group><article-title>Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation</article-title><source>Inflammation</source><volume>43</volume><fpage>1589</fpage><lpage>1598</lpage><year>2020</year><pub-id pub-id-type="doi">10.1007/s10753-020-01242-9</pub-id><?supplied-pmid 32410071?><pub-id pub-id-type="pmid">32410071</pub-id></element-citation></ref><ref id="b11-mmr-0-0-11716"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>G</given-names></name><name><surname>Jian</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Ma</surname><given-names>R</given-names></name><name><surname>Tang</surname><given-names>F</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name></person-group><article-title>Sirt1 promotes autophagy and inhibits apoptosis to protect cardiomyocytes from hypoxic stress</article-title><source>Int J Mol Med</source><volume>43</volume><fpage>2033</fpage><lpage>2043</lpage><year>2019</year><?supplied-pmid 30864731?><pub-id pub-id-type="pmid">30864731</pub-id></element-citation></ref><ref id="b12-mmr-0-0-11716"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prola</surname><given-names>A</given-names></name><name><surname>Pires Da Silva</surname><given-names>J</given-names></name><name><surname>Guilbert</surname><given-names>A</given-names></name><name><surname>Lecru</surname><given-names>L</given-names></name><name><surname>Piquereau</surname><given-names>J</given-names></name><name><surname>Ribeiro</surname><given-names>M</given-names></name><name><surname>Mateo</surname><given-names>P</given-names></name><name><surname>Gressette</surname><given-names>M</given-names></name><name><surname>Fortin</surname><given-names>D</given-names></name><name><surname>Boursier</surname><given-names>C</given-names></name><etal/></person-group><article-title>SIRT1 protects the heart from ER stress-induced cell death through eIF2&#x003b1; deacetylation</article-title><source>Cell Death Differ</source><volume>24</volume><fpage>343</fpage><lpage>356</lpage><year>2017</year><pub-id pub-id-type="doi">10.1038/cdd.2016.138</pub-id><?supplied-pmid 27911441?><pub-id pub-id-type="pmid">27911441</pub-id></element-citation></ref><ref id="b13-mmr-0-0-11716"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasser</surname><given-names>SP</given-names></name></person-group><article-title>Medicinal Mushroom Science: History, Current Status, Future Trends, and Unsolved Problems</article-title><source>Int J Med Mushrooms</source><volume>12</volume><fpage>1</fpage><lpage>16</lpage><year>2010</year><pub-id pub-id-type="doi">10.1615/IntJMedMushr.v12.i1.10</pub-id></element-citation></ref><ref id="b14-mmr-0-0-11716"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>I-K</given-names></name><name><surname>Yun</surname><given-names>B-S</given-names></name></person-group><article-title>Styrylpyrone-class compounds from medicinal fungi <italic>Phellinus</italic> and <italic>Inonotus</italic> spp., and their medicinal importance</article-title><source>J Antibiot (Tokyo)</source><volume>64</volume><fpage>349</fpage><lpage>359</lpage><year>2011</year><pub-id pub-id-type="doi">10.1038/ja.2011.2</pub-id><?supplied-pmid 21304532?><pub-id pub-id-type="pmid">21304532</pub-id></element-citation></ref><ref id="b15-mmr-0-0-11716"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Javed</surname><given-names>S</given-names></name><name><surname>Mitchell</surname><given-names>K</given-names></name><name><surname>Sidsworth</surname><given-names>D</given-names></name><name><surname>Sellers</surname><given-names>SL</given-names></name><name><surname>Reutens-Hernandez</surname><given-names>J</given-names></name><name><surname>Massicotte</surname><given-names>HB</given-names></name><name><surname>Egger</surname><given-names>KN</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Payne</surname><given-names>GW</given-names></name></person-group><article-title><italic>Inonotus obliquus</italic> attenuates histamine-induced microvascular inflammation</article-title><source>PLoS One</source><volume>14</volume><fpage>e0220776</fpage><year>2019</year><pub-id pub-id-type="doi">10.1371/journal.pone.0220776</pub-id><?supplied-pmid 31437163?><pub-id pub-id-type="pmid">31437163</pub-id></element-citation></ref><ref id="b16-mmr-0-0-11716"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>Ding</surname><given-names>S</given-names></name><name><surname>Ai</surname><given-names>L</given-names></name><name><surname>Deng</surname><given-names>K</given-names></name></person-group><article-title>Antitumor and immunomodulatory activity of water-soluble polysaccharide from <italic>Inonotus obliquus</italic></article-title><source>Carbohydr Polym</source><volume>90</volume><fpage>870</fpage><lpage>874</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.carbpol.2012.06.013</pub-id><?supplied-pmid 22840014?><pub-id pub-id-type="pmid">22840014</pub-id></element-citation></ref><ref id="b17-mmr-0-0-11716"><label>17</label><element-citation publication-type="book"><article-title>National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals</article-title><source>Guide for the Care and Use of Laboratory Animals</source><edition>8th edition</edition><publisher-name>National Academies Press</publisher-name><publisher-loc>Washington, DC</publisher-loc><year>2011</year><?supplied-pmid 21123303?></element-citation></ref><ref id="b18-mmr-0-0-11716"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><?supplied-pmid 11846609?><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref><ref id="b19-mmr-0-0-11716"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balandaykin</surname><given-names>ME</given-names></name><name><surname>Zmitrovich</surname><given-names>IV</given-names></name></person-group><article-title>Review on Chaga Medicinal Mushroom, <italic>Inonotus obliquus</italic> (Higher Basidiomycetes): Realm of Medicinal Applications and Approaches on Estimating its Resource Potential</article-title><source>Int J Med Mushrooms</source><volume>17</volume><fpage>95</fpage><lpage>104</lpage><year>2015</year><pub-id pub-id-type="doi">10.1615/IntJMedMushrooms.v17.i2.10</pub-id><?supplied-pmid 25746615?><pub-id pub-id-type="pmid">25746615</pub-id></element-citation></ref><ref id="b20-mmr-0-0-11716"><label>20</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Effect of the <italic>Inonotus obliquus</italic> polysaccharides on blood lipid metabolism and oxidative stress of rats fed high-fat diet in vivo</article-title><source>Proceedings of the 2009 2nd International Conference on Biomedical Engineering and Informatics</source><publisher-name>IEEE</publisher-name><publisher-loc>New York, NY</publisher-loc><fpage>1114</fpage><lpage>1117</lpage><year>2009</year></element-citation></ref><ref id="b21-mmr-0-0-11716"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalogeris</surname><given-names>T</given-names></name><name><surname>Baines</surname><given-names>CP</given-names></name><name><surname>Krenz</surname><given-names>M</given-names></name><name><surname>Korthuis</surname><given-names>RJ</given-names></name></person-group><article-title>Ischemia/Reperfusion</article-title><source>Compr Physiol</source><volume>7</volume><fpage>113</fpage><lpage>170</lpage><year>2016</year><pub-id pub-id-type="doi">10.1002/cphy.c160006</pub-id><?supplied-pmid 28135002?><pub-id pub-id-type="pmid">28135002</pub-id></element-citation></ref><ref id="b22-mmr-0-0-11716"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horwitz</surname><given-names>LD</given-names></name><name><surname>Wallner</surname><given-names>JS</given-names></name><name><surname>Decker</surname><given-names>DE</given-names></name><name><surname>Buxser</surname><given-names>SE</given-names></name></person-group><article-title>Efficacy of lipid soluble, membrane-protective agents against hydrogen peroxide cytotoxicity in cardiac myocytes</article-title><source>Free Radic Biol Med</source><volume>21</volume><fpage>743</fpage><lpage>753</lpage><year>1996</year><pub-id pub-id-type="doi">10.1016/0891-5849(96)00177-3</pub-id><?supplied-pmid 8902520?><pub-id pub-id-type="pmid">8902520</pub-id></element-citation></ref><ref id="b23-mmr-0-0-11716"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raedschelders</surname><given-names>K</given-names></name><name><surname>Ansley</surname><given-names>DM</given-names></name><name><surname>Chen</surname><given-names>DD</given-names></name></person-group><article-title>The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion</article-title><source>Pharmacol Ther</source><volume>133</volume><fpage>230</fpage><lpage>255</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.pharmthera.2011.11.004</pub-id><?supplied-pmid 22138603?><pub-id pub-id-type="pmid">22138603</pub-id></element-citation></ref><ref id="b24-mmr-0-0-11716"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>T</given-names></name><name><surname>Farrar</surname><given-names>S</given-names></name><name><surname>Ji</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name></person-group><article-title>Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species</article-title><source>Cell Physiol Biochem</source><volume>44</volume><fpage>532</fpage><lpage>553</lpage><year>2017</year><pub-id pub-id-type="doi">10.1159/000485089</pub-id><?supplied-pmid 29145191?><pub-id pub-id-type="pmid">29145191</pub-id></element-citation></ref><ref id="b25-mmr-0-0-11716"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>WW</given-names></name><name><surname>Xu</surname><given-names>HL</given-names></name><name><surname>Yu</surname><given-names>XF</given-names></name><name><surname>Lyu</surname><given-names>C</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Sui</surname><given-names>D</given-names></name></person-group><article-title>20(S)-Ginsenoside Rg2 attenuates myocardial ischemia/reperfusion injury by reducing oxidative stress and inflammation: Role of SIRT1</article-title><source>Rsc Adv</source><volume>8</volume><fpage>23947</fpage><lpage>23962</lpage><year>2018</year><pub-id pub-id-type="doi">10.1039/C8RA02316F</pub-id></element-citation></ref><ref id="b26-mmr-0-0-11716"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotchkiss</surname><given-names>RS</given-names></name><name><surname>Strasser</surname><given-names>A</given-names></name><name><surname>McDunn</surname><given-names>JE</given-names></name><name><surname>Swanson</surname><given-names>PE</given-names></name></person-group><article-title>Cell death</article-title><source>N Engl J Med</source><volume>361</volume><fpage>1570</fpage><lpage>1583</lpage><year>2009</year><pub-id pub-id-type="doi">10.1056/NEJMra0901217</pub-id><?supplied-pmid 19828534?><pub-id pub-id-type="pmid">19828534</pub-id></element-citation></ref><ref id="b27-mmr-0-0-11716"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>JD</given-names></name><name><surname>Miao</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Wolfson</surname><given-names>A</given-names></name><name><surname>Pennathur</surname><given-names>S</given-names></name><name><surname>Pipe</surname><given-names>SW</given-names></name><name><surname>Kaufman</surname><given-names>RJ</given-names></name></person-group><article-title>Antioxidants reduce endoplasmic reticulum stress and improve protein secretion</article-title><source>Proc Natl Acad Sci USA</source><volume>105</volume><fpage>18525</fpage><lpage>18530</lpage><year>2008</year><pub-id pub-id-type="doi">10.1073/pnas.0809677105</pub-id><?supplied-pmid 19011102?><pub-id pub-id-type="pmid">19011102</pub-id></element-citation></ref><ref id="b28-mmr-0-0-11716"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hetz</surname><given-names>C</given-names></name></person-group><article-title>The unfolded protein response: Controlling cell fate decisions under ER stress and beyond</article-title><source>Nat Rev Mol Cell Biol</source><volume>13</volume><fpage>89</fpage><lpage>102</lpage><year>2012</year><pub-id pub-id-type="doi">10.1038/nrm3270</pub-id><?supplied-pmid 22251901?><pub-id pub-id-type="pmid">22251901</pub-id></element-citation></ref><ref id="b29-mmr-0-0-11716"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louessard</surname><given-names>M</given-names></name><name><surname>Bardou</surname><given-names>I</given-names></name><name><surname>Lemarchand</surname><given-names>E</given-names></name><name><surname>Thiebaut</surname><given-names>AM</given-names></name><name><surname>Parcq</surname><given-names>J</given-names></name><name><surname>Leprince</surname><given-names>J</given-names></name><name><surname>Terrisse</surname><given-names>A</given-names></name><name><surname>Carraro</surname><given-names>V</given-names></name><name><surname>Fafournoux</surname><given-names>P</given-names></name><name><surname>Bruhat</surname><given-names>A</given-names></name><etal/></person-group><article-title>Activation of cell surface GRP78 decreases endoplasmic reticulum stress and neuronal death</article-title><source>Cell Death Differ</source><volume>24</volume><fpage>1518</fpage><lpage>1529</lpage><year>2017</year><pub-id pub-id-type="doi">10.1038/cdd.2017.35</pub-id><?supplied-pmid 28644439?><pub-id pub-id-type="pmid">28644439</pub-id></element-citation></ref><ref id="b30-mmr-0-0-11716"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniuchi</surname><given-names>S</given-names></name><name><surname>Miyake</surname><given-names>M</given-names></name><name><surname>Tsugawa</surname><given-names>K</given-names></name><name><surname>Oyadomari</surname><given-names>M</given-names></name><name><surname>Oyadomari</surname><given-names>S</given-names></name></person-group><article-title>Integrated stress response of vertebrates is regulated by four eIF2&#x003b1; kinases</article-title><source>Sci Rep</source><volume>6</volume><fpage>32886</fpage><year>2016</year><pub-id pub-id-type="doi">10.1038/srep32886</pub-id><?supplied-pmid 27633668?><pub-id pub-id-type="pmid">27633668</pub-id></element-citation></ref><ref id="b31-mmr-0-0-11716"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabas</surname><given-names>I</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><article-title>Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress</article-title><source>Nat Cell Biol</source><volume>13</volume><fpage>184</fpage><lpage>190</lpage><year>2011</year><pub-id pub-id-type="doi">10.1038/ncb0311-184</pub-id><?supplied-pmid 21364565?><pub-id pub-id-type="pmid">21364565</pub-id></element-citation></ref><ref id="b32-mmr-0-0-11716"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Morishima</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Yankner</surname><given-names>BA</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name></person-group><article-title>Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta</article-title><source>Nature</source><volume>403</volume><fpage>98</fpage><lpage>103</lpage><year>2000</year><pub-id pub-id-type="doi">10.1038/47513</pub-id><?supplied-pmid 10638761?><pub-id pub-id-type="pmid">10638761</pub-id></element-citation></ref><ref id="b33-mmr-0-0-11716"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>TJ</given-names></name><name><surname>Han</surname><given-names>LH</given-names></name><name><surname>Cong</surname><given-names>RS</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name></person-group><article-title>Caspase family proteases and apoptosis</article-title><source>Acta Biochim Biophys Sin (Shanghai)</source><volume>37</volume><fpage>719</fpage><lpage>727</lpage><year>2005</year><pub-id pub-id-type="doi">10.1111/j.1745-7270.2005.00108.x</pub-id><?supplied-pmid 16270150?><pub-id pub-id-type="pmid">16270150</pub-id></element-citation></ref><ref id="b34-mmr-0-0-11716"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>Z</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Yi</surname><given-names>D</given-names></name></person-group><article-title>Novel role of silent information regulator 1 in myocardial ischemia</article-title><source>Circulation</source><volume>128</volume><fpage>2232</fpage><lpage>2240</lpage><year>2013</year><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.002480</pub-id><?supplied-pmid 24218438?><pub-id pub-id-type="pmid">24218438</pub-id></element-citation></ref><ref id="b35-mmr-0-0-11716"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hetz</surname><given-names>C</given-names></name><name><surname>Chevet</surname><given-names>E</given-names></name><name><surname>Harding</surname><given-names>HP</given-names></name></person-group><article-title>Targeting the unfolded protein response in disease</article-title><source>Nat Rev Drug Discov</source><volume>12</volume><fpage>703</fpage><lpage>719</lpage><year>2013</year><pub-id pub-id-type="doi">10.1038/nrd3976</pub-id><?supplied-pmid 23989796?><pub-id pub-id-type="pmid">23989796</pub-id></element-citation></ref><ref id="b36-mmr-0-0-11716"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winnik</surname><given-names>S</given-names></name><name><surname>Auwerx</surname><given-names>J</given-names></name><name><surname>Sinclair</surname><given-names>DA</given-names></name><name><surname>Matter</surname><given-names>CM</given-names></name></person-group><article-title>Protective effects of sirtuins in cardiovascular diseases: From bench to bedside</article-title><source>Eur Heart J</source><volume>36</volume><fpage>3404</fpage><lpage>3412</lpage><year>2015</year><pub-id pub-id-type="doi">10.1093/eurheartj/ehv290</pub-id><?supplied-pmid 26112889?><pub-id pub-id-type="pmid">26112889</pub-id></element-citation></ref><ref id="b37-mmr-0-0-11716"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>LQ</given-names></name><name><surname>Fan</surname><given-names>ZQ</given-names></name><name><surname>Tang</surname><given-names>YF</given-names></name><name><surname>Ke</surname><given-names>ZJ</given-names></name></person-group><article-title>The resveratrol attenuates ethanol-induced hepatocyte apoptosis via inhibiting ER-related caspase-12 activation and PDE activity in vitro</article-title><source>Alcohol Clin Exp Res</source><volume>38</volume><fpage>683</fpage><lpage>693</lpage><year>2014</year><pub-id pub-id-type="doi">10.1111/acer.12311</pub-id><?supplied-pmid 24224909?><pub-id pub-id-type="pmid">24224909</pub-id></element-citation></ref><ref id="b38-mmr-0-0-11716"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubbard</surname><given-names>BP</given-names></name><name><surname>Gomes</surname><given-names>AP</given-names></name><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Case</surname><given-names>AW</given-names></name><name><surname>Considine</surname><given-names>T</given-names></name><name><surname>Riera</surname><given-names>TV</given-names></name><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>E</surname><given-names>SY</given-names></name><name><surname>Lamming</surname><given-names>DW</given-names></name><etal/></person-group><article-title>Evidence for a common mechanism of SIRT1 regulation by allosteric activators</article-title><source>Science</source><volume>339</volume><fpage>1216</fpage><lpage>1219</lpage><year>2013</year><pub-id pub-id-type="doi">10.1126/science.1231097</pub-id><?supplied-pmid 23471411?><pub-id pub-id-type="pmid">23471411</pub-id></element-citation></ref><ref id="b39-mmr-0-0-11716"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name></person-group><article-title>Signal integration in the endoplasmic reticulum unfolded protein response</article-title><source>Nat Rev Mol Cell Biol</source><volume>8</volume><fpage>519</fpage><lpage>529</lpage><year>2007</year><pub-id pub-id-type="doi">10.1038/nrm2199</pub-id><?supplied-pmid 17565364?><pub-id pub-id-type="pmid">17565364</pub-id></element-citation></ref><ref id="b40-mmr-0-0-11716"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pires Da Silva</surname><given-names>J</given-names></name><name><surname>Monceaux</surname><given-names>K</given-names></name><name><surname>Guilbert</surname><given-names>A</given-names></name><name><surname>Gressette</surname><given-names>M</given-names></name><name><surname>Piquereau</surname><given-names>J</given-names></name><name><surname>Novotova</surname><given-names>M</given-names></name><name><surname>Ventura-Clapier</surname><given-names>R</given-names></name><name><surname>Garnier</surname><given-names>A</given-names></name><name><surname>Lemaire</surname><given-names>C</given-names></name></person-group><article-title>SIRT1 Protects the Heart from ER Stress-Induced Injury by Promoting eEF2K/eEF2-Dependent Autophagy</article-title><source>Cells</source><volume>9</volume><fpage>426</fpage><year>2020</year><pub-id pub-id-type="doi">10.3390/cells9020426</pub-id></element-citation></ref><ref id="b41-mmr-0-0-11716"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>YJ</given-names></name><name><surname>Hsu</surname><given-names>SC</given-names></name><name><surname>Hsu</surname><given-names>CP</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Chang</surname><given-names>YL</given-names></name><name><surname>Sadoshima</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>SM</given-names></name><name><surname>Tsai</surname><given-names>CS</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name></person-group><article-title>Sirtuin 1 protects the aging heart from contractile dysfunction mediated through the inhibition of endoplasmic reticulum stress-mediated apoptosis in cardiac-specific Sirtuin 1 knockout mouse model</article-title><source>Int J Cardiol</source><volume>228</volume><fpage>543</fpage><lpage>552</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.ijcard.2016.11.247</pub-id><?supplied-pmid 27875732?><pub-id pub-id-type="pmid">27875732</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-mmr-0-0-11716" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>IOE improves cardiac function. (A) Echocardiography images of each group. Bar graphs of (B) LVIDd, (C) LVIDs, (D) LVEF and (E) LVFS. Data are presented as the mean &#x000b1; standrd deviation. n=10. <sup>##</sup>P&#x0003c;0.01 vs. Sham. *P&#x0003c;0.05 and **P&#x0003c;0.01 vs. MI/R. IOE, <italic>Inonotus obliquus</italic> extract; LV, left ventricular; LVIDd, LV internal dimensions at diastole; LVIDs, LV internal diameter systole; LVEF, LV ejection fraction; LVFS, LV fractional shortening; MI/R, myocardial ischemia/reperfusion.</p></caption><graphic xlink:href="mmr-23-01-11716-g00"/></fig><fig id="f2-mmr-0-0-11716" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>IOE decreases infarct size and attenuates MI/R injury. (A) Representative images of heart tissues. Normal myocardial tissues are dark red and ischemic myocardial tissues are pale. The MIS was calculated as the ischemic myocardial weight/wet weight of left ventricle &#x000d7;100%. The levels of (B) CK-MB, (C) LDH and (D) AST in serum. Data are presented as the mean &#x000b1; standard deviation. n=10. <sup>##</sup>P&#x0003c;0.01 vs. Sham. **P&#x0003c;0.01 vs. MI/R. IOE, <italic>Inonotus obliquus</italic> extract; MI/R, myocardial ischemia/reperfusion; CK-MB, creatine kinase MB, LDG, lactate dehydrogenase; AST, aminotransferase; MIS, myocardial infarction size.</p></caption><graphic xlink:href="mmr-23-01-11716-g01"/></fig><fig id="f3-mmr-0-0-11716" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>IOE relieves the histopathological changes in myocardial tissue. Representative hematoxylin and eosin staining images of myocardial slices at &#x000d7;200 magnification (upper panel; scale bar, 50 &#x000b5;m) and &#x000d7;400 magnification (lower panel; scale bar, 25 &#x000b5;m). n=4. IOE, <italic>Inonotus obliquus</italic> extract; MI/R, myocardial ischemia/reperfusion.</p></caption><graphic xlink:href="mmr-23-01-11716-g02"/></fig><fig id="f4-mmr-0-0-11716" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>IOE protects cardiomyocytes against oxidative stress. The activity of (A) SOD, the content of (B) MDA, the activity of (C) GSH-px and the activity of (D) CAT. Data are presented as the mean &#x000b1; standard deviation. n=10. <sup>##</sup>P&#x0003c;0.01 vs. Sham. **P&#x0003c;0.01 vs. MI/R. IOE, <italic>Inonotus obliquus</italic> extract; SOD, superoxide dismutase; GSH-px, glutathione peroxidase; CAT, catalase; MDA, malondialdehyde; MI/R, myocardial ischemia/reperfusion.</p></caption><graphic xlink:href="mmr-23-01-11716-g03"/></fig><fig id="f5-mmr-0-0-11716" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>IOE decreases cardiomyocyte apoptosis. (A) Representative images of TUNEL staining (scale bar, 100 &#x000b5;m). (B) Cardiomyocyte apoptosis index. Data are presented as the mean &#x000b1; standard deviation. n=4. <sup>##</sup>P&#x0003c;0.01 vs. Sham. *P&#x0003c;0.05, **P&#x0003c;0.01 vs. MI/R. IOE, <italic>Inonotus obliquus</italic> extract; MI/R, myocardial ischemia/reperfusion.</p></caption><graphic xlink:href="mmr-23-01-11716-g04"/></fig><fig id="f6-mmr-0-0-11716" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>Expression of SIRT1, GRP78, p-PERK, p-eIF2&#x003b1;, CHOP, caspase-12 and the mRNA levels of <italic>caspase-12</italic> in the myocardium. (A) Representative blots of SIRT1, GRP78, p-PERK, p-eIF2&#x003b1;, CHOP and caspase-12. Semiquantitative analysis of (B) SIRT1, (C) GRP78, (D) p-PERK, (E) p-eIF2&#x003b1;, (F) CHOP and (G) caspase-12. (H) The mRNA levels of <italic>caspase-12</italic> in the myocardium. Data are presented as the mean &#x000b1; standard deviation. n=3. <sup>##</sup>P&#x0003c;0.01 vs. Sham. *P&#x0003c;0.05 and **P&#x0003c;0.01 vs. MI/R. IOE, <italic>Inonotus obliquus</italic> extract; SIRT1, NAD-dependent protein deacetylase sirtuin-1; GRP78, glucose-regulated protein 78; PERK, protein kinase R-like endoplasmic reticulum kinase; eIF2&#x003b1;, eukaryotic translation initiation factor 2 subunit &#x003b1;; CHOP, C/EBP homologous protein; p, phosphorylated; MI/R, myocardial ischemia/reperfusion.</p></caption><graphic xlink:href="mmr-23-01-11716-g05"/></fig><fig id="f7-mmr-0-0-11716" orientation="portrait" position="float"><label>Figure 7.</label><caption><p>Expression of pro-caspase-9 and pro-caspase-3 in the myocardium. (A) Representative blots of pro-caspase-9 and pro-caspase-3. Semiquantitative analysis of (B) pro-caspase-9 and (C) pro-caspase-3. Data are presented as the mean &#x000b1; standard deviation. n=3. <sup>##</sup>P&#x0003c;0.01 vs. Sham. **P&#x0003c;0.01 vs. MI/R. MI/R, myocardial ischemia/reperfusion; IOE, <italic>Inonotus obliquus</italic> extract.</p></caption><graphic xlink:href="mmr-23-01-11716-g06"/></fig></floats-group></article>